DYRK3 and oral cavity squamous cell carcinoma: This dysregulation of the PAICS/DYRK3 axis serves as a key modulator, influencing treatment effectors and contributing to tumorigenicity, disease progression, and therapy evasion in patients with oral squamous cell carcinoma.